Skip to content

13F-HR filed by JACOBS LEVY EQUITY MANAGEMENT, INC

JACOBS LEVY EQUITY MANAGEMENT, INC filed this 13F-HR for the quarter ended 2021-06-30, filed 2021-08-16, with 1,017 holding rows worth $14,751,395,000.

Accession
0001085146-21-002519
Filed
2021-08-16
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q2 2021

A combination report, 1,017 entries on the cover page, a total value of $14,751,395,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $14,751,395,000 with VALUE read as thousands by filing date, 13F file number 028-03059. The quarter's positions are built on this report. The resolved quarter.

Other managers

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
VERA BRADLEY INC92335C106COM12,395$154,000thousands by filing date
PC TEL INC69325Q105COM23,272$152,000thousands by filing date
CROSSFIRST BANKSHARES INC22766M109COM10,759$148,000thousands by filing date
FULCRUM THERAPEUTICS INC359616109COMMON STOCK13,789$145,000thousands by filing date
LUTHER BURBANK CORP550550107COM12,109$144,000thousands by filing date
ALTA EQUIPMENT GROUP INC COMMON STOCK02128L106Stock10,143$135,000thousands by filing date
AMERICAN FINANCE TRUST INC02607T109COM CLASS A15,119$128,000thousands by filing date
DECIBEL THERAPEUTICS INC24343R106COM13,594$117,000thousands by filing date
CRAWFORD &amp CO224633107COM13,330$115,000thousands by filing date
IMARA INC45249V107COM13,794$109,000thousands by filing date
MANITEX INTL INC563420108COMMON STOCK14,300$104,000thousands by filing date
FORTRESS BIOTECH INC34960Q109COM24,609$88,000thousands by filing date
LEAP THERAPEUTICS INC52187K101COM51,714$85,000thousands by filing date
PRECIGEN INC74017N105COM11,359$74,000thousands by filing date
PIXELWORKS INC72581M305COM NEW19,075$65,000thousands by filing date
METACRINE INC59101E103COM14,284$54,000thousands by filing date
SURGALIGN HOLDINGS INC86882C105COM16,710$23,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001085146-21-002519this filing2021-08-16acceptance time not in the bulk data set